chr15-43523109-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_002373.6(MAP1A):āc.1636C>Gā(p.Leu546Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002373.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP1A | NM_002373.6 | c.1636C>G | p.Leu546Val | missense_variant | 4/6 | ENST00000300231.6 | NP_002364.5 | |
MAP1A | NM_001411089.1 | c.2350C>G | p.Leu784Val | missense_variant | 5/7 | NP_001398018.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP1A | ENST00000300231.6 | c.1636C>G | p.Leu546Val | missense_variant | 4/6 | 5 | NM_002373.6 | ENSP00000300231 | P2 | |
MAP1A | ENST00000382031.5 | c.2350C>G | p.Leu784Val | missense_variant | 5/7 | 5 | ENSP00000371462 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249522Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135382
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461890Hom.: 0 Cov.: 37 AF XY: 0.00000550 AC XY: 4AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.1636C>G (p.L546V) alteration is located in exon 4 (coding exon 1) of the MAP1A gene. This alteration results from a C to G substitution at nucleotide position 1636, causing the leucine (L) at amino acid position 546 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at